Weight loss drugmakers lobby for Medicare Coverage

Wall Street Journal

24 April 2023 - Adding Ozempic, Mounjaro to federal plans could stoke sales.

Weight loss drug makers are lobbying Congress to grant them access to a monster payday for their blockbuster treatments: Medicare coverage.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Market access